List of insiders holdings for SAB Biotherapeutics Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| Hamilton Edward D. 10% Owner | 2021-10-26 21:51:00 | 2,668,049 7,299,915 | 9,967,964 | Form 4 |
| HAMILTON CHRISTINE E Director 10% Owner | 2023-02-10 16:14:04 | 4,993,090 3,108,270 | 8,101,360 | Form 5 |
| Moin Andrew Director | 2023-11-28 16:05:14 | 0 4,612,951 | 4,612,951 | Form 4 |
| Sessa Capital (Master) L.P. Sessa Capital GP LLC Sessa Capital IM L.P. Sessa Capital IM GP LLC Petry John Director | 2023-11-28 16:05:50 | 4,612,951 0 | 4,612,951 | Form 4 |
| Katz Ilan Director 10% Owner | 2021-10-15 10:51:05 | 1500 3,047,825 | 3,049,325 | Form 4 |
| Ellias Helen K. Director | 2023-11-28 16:05:09 | 0 2,857,142 | 2,857,142 | Form 4 |
| Big Cypress Holdings LLC CEO and CFO 10% Owner | 2022-05-27 16:24:59 | 965,299 0 | 965,299 | Form 13D |
| Randall Charles Hiram Chief Strategy Officer | 2021-10-26 21:46:48 | 506,276 0 | 506,276 | Form 4 |
| Reich Samuel J CEO & EXECUTIVE CHAIRMAN | 2024-02-23 16:40:16 | 434,000 0 | 434,000 | Form 4 |
| Beyer Russell P Chief Financial Officer | 2023-03-16 16:27:20 | 275,000 0 | 275,000 | Form 4 |
| Sullivan Eddie Joe PRESIDENT | 2024-02-23 16:55:10 | 190,000 0 | 190,000 | Form 4 |
| Polvino William James Director | 2021-11-22 14:31:22 | 151,333 0 | 151,333 | Form 4/A |
| Kropotova Alexandra CHIEF MEDICAL OFFICER | 2024-02-23 17:00:34 | 140,000 0 | 140,000 | Form 4 |
| Bausch Christoph Lawrence CHIEF OPERATING OFFICER | 2024-02-23 16:50:07 | 140,000 0 | 140,000 | Form 4 |
| Wu Hua SVP Research & Product Dev. | 2021-10-26 21:52:27 | 111,871 4653 | 116,524 | Form 4 |
| King Michael CHIEF FINANCIAL OFFICER | 2024-02-23 16:45:19 | 115,000 0 | 115,000 | Form 4 |
| Link David Charles Director | 2022-12-09 09:01:53 | 98,806 0 | 98,806 | Form 4 |
| Turner Mervyn Director | 2021-10-26 21:49:46 | 79,192 0 | 79,192 | Form 4 |
| Giberson Scott Director | 2022-09-15 17:00:13 | 25,000 0 | 25,000 | Form 4 |
| Lucera Erick Director | 2023-04-05 17:01:45 | 25,000 0 | 25,000 | Form 4 |
| Finnegan Frederick Chief Business Officer | 2022-03-18 21:15:43 | 23,453 0 | 23,453 | Form 4 |
| Luke Thomas Charles Chief Medical Officer | 2022-03-18 21:15:47 | 20,519 0 | 20,519 | Form 4 |
| Spragens Jeffrey G Director | 2023-03-02 09:20:24 | 19,936 0 | 19,936 | Form 4 |
| Erickson Bruce Kipp Chief Operating Officer | 2022-03-18 21:15:14 | 18,196 0 | 18,196 | Form 4 |
| Carillo Carlos N SVP Regulatory Affairs | 2021-10-26 21:53:55 | 17,681 0 | 17,681 | Form 4 |
| Ullerich Melissa Vera Chief Communications Officer | 2022-03-18 21:15:35 | 16,405 0 | 16,405 | Form 4 |
| Pommer Jerry Lynn Chief Compliance Officer | 2022-03-18 21:15:30 | 15,172 0 | 15,172 | Form 4 |
| Collins Stephen D. Director | 2021-01-11 16:52:55 | 0 0 | 0 | Form 3 |
| Martin James Joseph Director | 2021-01-11 16:57:58 | 0 0 | 0 | Form 3 |